Plasmacytoid dendritic cells regulate megakaryocyte and platelet homeostasis
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Platelet homeostasis is essential for vascular integrity and immune defense. While the process of platelet formation by fragmenting megakaryocytes (thrombopoiesis) has been extensively studied, the cellular and molecular mechanisms required to constantly replenish the pool of megakaryocytes by their progenitor cells (megakaryopoiesis) remains unclear. Here we use intravital 2 photon microscopy to track individual megakaryopoiesis over days. We identify plasmacytoid dendritic cells (pDCs) as crucial bone marrow niche cells that regulate megakaryopoiesis. pDCs monitor the bone marrow for platelet-producing megakaryocytes and deliver IFN-α to the megakaryocytic niche to trigger local on-demand proliferation of megakaryocyte progenitors. This fine-tuned coordination between thrombopoiesis and megakaryopoiesis is crucial for megakaryocyte and platelet homeostasis in steady state and stress. However, uncontrolled pDC function within the megakaryocytic niche is detrimental. Accordingly, we show that pDCs activated by SARS-CoV2 drive inappropriate megakaryopoiesis associated with thrombotic complications. Together, we uncover a hitherto unknown megakaryocytic bone marrow niche maintained by the constitutive delivery of pDC-derived IFN-α.
Article activity feed
-
SciScore for 10.1101/2022.05.31.494147: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The study was approved by and conducted according to requirements of the ethics committees at the Ludwig Maximilians University of Munich (20-1039).
IACUC: All experimental animal procedures were approved by the Institutional Animal Committee of the San Raffaele Scientific Institute and all infectious work was performed in designed BSL-3 workspaces.
Euthanasia Agents: After imaging the mice were euthanized by cervical dislocation.Sex as a biological variable Both male and female mice were used in this study. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Antibodies Sentences Resources Platelet depleting antibodies (R300, anti-GPIbα) and isotype … SciScore for 10.1101/2022.05.31.494147: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The study was approved by and conducted according to requirements of the ethics committees at the Ludwig Maximilians University of Munich (20-1039).
IACUC: All experimental animal procedures were approved by the Institutional Animal Committee of the San Raffaele Scientific Institute and all infectious work was performed in designed BSL-3 workspaces.
Euthanasia Agents: After imaging the mice were euthanized by cervical dislocation.Sex as a biological variable Both male and female mice were used in this study. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Antibodies Sentences Resources Platelet depleting antibodies (R300, anti-GPIbα) and isotype control (C301) were purchased from Emfret (Eibelstadt, Germany) and used according to the manufacturer’s protocol. anti-GPIbαsuggested: NoneC301suggested: NonepDC depleting antibody (ultra-LEAFTM purified anti-PDCA-1, clone 927, BioLegend) was injected i.p. for 9 consecutive days with a concentration of 150 µg per mouse at day 1 and 100 µg per mouse the following days. anti-PDCA-1suggested: NoneTo monitor pDC activation and IFN alpha production, the following primary antibodies were used: CD69 mouse anti-human (#MA5-15612 Thermo Fisher) CD69 mouse anti-humansuggested: Noneanti-humansuggested: (Millipore Cat# 4700-0360, RRID:AB_11210063)Secondary antibodies (1:200): donkey anti-rabbit-AF488, donkey anti-mouse-AF 555, and donkey anti-gost-AF647. anti-rabbit-AF488suggested: Noneanti-mouse-AFsuggested: Noneanti-gost-AF647suggested: NoneLineage-biotin antibodies (Ter-119, CD3e, CD45R, CD11b, Ly-6G,) and streptavidin-PE were used with dilution of 1:200, all antibodies were purchased from eBioscience (San Diego, USA) Lineage-biotinsuggested: NoneCD3esuggested: (Thermo Fisher Scientific Cat# 88-7774-75, RRID:AB_476399)CD45Rsuggested: (Thermo Fisher Scientific Cat# 88-7774-75, RRID:AB_476399)CD11bsuggested: (BD Biosciences Cat# 558074, RRID:AB_1645213)Ly-6G ,suggested: NoneThe following antibodies were used to identify MKs: 1:100 anti-mouse CD41-FITC+ and anti-mouse CD42d-APC+ (BioLegend); and MKPs: anti-mouse CD41-FITC+, Pacific blue lineage negative (Ter-119-, CD3e-, CD45R-, CD11b-, Ly-6G-) anti-mouse CD42d-APC+suggested: Noneanti-mouse CD41-FITC+suggested: NoneTer-119- , CD3e-suggested: NoneLy-6G-suggested: NoneWe identified pDCs using the following antibodies: anti-mouse SiglecH-FITC+, CD11b-PE-Cy7-, B220-APC+ from BioLegend (San Diego, USA) ( anti-mousesuggested: None1:200). pDC activation: anti-mouse CD69-FITC, CD86-PE, CD11b-APC-Cy7, CD317-APC, SiglecH-PercCy5.5 antibodies all from BioLegend and Life/Dead marker (405 nm excitation; ThermoFisher). anti-mouse CD69-FITCsuggested: (SouthernBiotech Cat# 1715-02, RRID:AB_2795177)IFN expression by pDCs: Following staining with pDC surface markers (see above), cells were fixed with PFA and methanol and stained with monoclonal anti-mouse p-IRF7 antibody (cellsignaling, clone D6M2I) in Perm buffer III (BD) as previously described31. anti-mouse p-IRF7suggested: NoneBriefly, cells were stained with surface marker antibodies (CD41, CD42) for 30 min RT in dark, followed by fixation for 15 min (4% PFA, provided in the kit) and permeabilization 15 min (saponin-based permeabilization and wash reagent, provided in the kit). CD41suggested: NoneExperimental Models: Organisms/Strains Sentences Resources Materials: Mouse strains: C57BL/6J, PF4-Cre (C57BL/6-Tg(Pf4-icre)Q3Rsko/J)44, Rosa26-iDTRflox (C57BL/6Gt(ROSA)26Sortm1(HBEGF)Awai/J)45, IFNαR-/- (B6.129S2-Ifnar1tm1Agt/Mmjax)46, IFNαR1flox (B6(Cg)-Ifnar1tm1.1Ees/J)47 and BDCA2-DTR (C57BL/6-Tg(CLEC4C-HBEGF)956Cln/J)(referred to as pDC-DTR)48 mice were purchased from The Jackson Laboratory. vWF-Cre mice were generated by W. C57BL/6Jsuggested: NonePF4-Cresuggested: NoneC57BL/6-Tg(Pf4-icre)Q3Rsko/J)44suggested: NoneRosa26-iDTRfloxsuggested: NoneC57BL/6Gt(ROSA)26Sortm1suggested: NoneB6.129S2-Ifnar1tm1Agt/Mmjax)46, IFNαR1floxsuggested: NoneC57BL/6-Tg(CLEC4C-HBEGF)956Cln/J)suggested: RRID:IMSR_JAX:014176)PF4-Cre were crossed with Rosa26-iDTR mice to induce megakaryocyte cell death in vivo (PF4-Cre; RS26-iDTR)18. PF4-Cre;RS26-iDTR were crossed with vWF-eGFP to visualize the megakaryocytic lineage following induction of MK cell death (referred to as MK-iDTR). Rosa26-iDTRsuggested: NonevWF-Cre mice were crossed with IFNαR1floxto conditionally delete IFNaR in the megakaryocytic lineage. pDC-DTR and IFNαR-/- were cross bred to achieve pDC depletion in IFNaR-/- animals (pDC-DTR; IFNaR-/-). vWF-Cresuggested: NoneDrug treatments: Diphtheria Toxin (DT) was purchased from Sigma-Aldrich (322326, Saint Louis, MO, USA) and was injected intraperitoneally into pDC-DTR- and pDC-DTR-IFNαR-/- mice with a dose of 8 ng/g per day for consecutive 3 days. pDC-DTR-IFNαR-/-suggested: NoneMouse model of SARS-CoV2 infection: B6.Cg-Tg(K18-ACE2)2Prlmn/J mice (on a C57BL/6 background) were purchased from The Jackson Laboratory and bred against FVB mice to obtain C57BL/6 x FVB F1 hybrids. B6.Cg-Tg(K18-ACE2)2Prlmn/Jsuggested: RRID:IMSR_JAX:034860)C57BL/6suggested: NoneFVBsuggested: NoneBlood vessel were visualized by i.v. injection of Dextran Tetramethylrhodamine (TRITC-Dextran, 100µg in 100µl solution, ThermoFisher Scientific) or Dextran Cascade Blue 10.000 MW (D1976, ThermoFisher Scientific) before imaging. vWF-eGFP mice was used to visualize the megakaryocytic lineage; pDCs were labeled with SiglecH-PE antibody (eBioscience) injected intravenously 20 min before imaging (20 µl diluted with 100 µl NaCl). vWF-eGFPsuggested: NoneRecombinant DNA Sentences Resources vWF-Cre mice were crossed with IFNαR1floxto conditionally delete IFNaR in the megakaryocytic lineage. pDC-DTR and IFNαR-/- were cross bred to achieve pDC depletion in IFNaR-/- animals (pDC-DTR; IFNaR-/-). pDC-DTRsuggested: NoneDrug treatments: Diphtheria Toxin (DT) was purchased from Sigma-Aldrich (322326, Saint Louis, MO, USA) and was injected intraperitoneally into pDC-DTR- and pDC-DTR-IFNαR-/- mice with a dose of 8 ng/g per day for consecutive 3 days. pDC-DTR-suggested: NoneSoftware and Algorithms Sentences Resources Animals were bred and maintained in the animal facilities of the Walter-Brendel Zentrum, the Zentrum für Neuropathologie und Neuropathologiesuggested: NoneLabelling of MKs/MKPs: primary: CD41-FITC+ and CD42-purified hamster anti-mouse (BioLegend); secondary: goat anti-hamster Alexa Fluor 647 (Abcam) (1:100). BioLegend)suggested: (BioLegend, RRID:SCR_001134)Images were taken with step size of 2 µm, range in z-stack of 40 µm, and analyzed with Zen Blue software. Zen Bluesuggested: (ZEN Digital Imaging for Light Microscopy, RRID:SCR_013672)Cell volumes of 3D rendered bone marrow stacks were measured automatically in Imaris. Imarissuggested: (Imaris, RRID:SCR_007370)Gene set enrichment analysis (GSEA): To prepare the data for GSEA, DESeq2 analysis was performed using Galaxy and default parameters51, 52. Gene set enrichment analysissuggested: (Gene Set Enrichment Analysis, RRID:SCR_003199)DESeq2suggested: (DESeq, RRID:SCR_000154)For further analysis, the tool GSEA (version 4.0.3) of UC San Diego and Broad Institute was used53 and 54, referring to their RNASeq manual pages for analysis. GSEAsuggested: (SeqGSEA, RRID:SCR_005724)Statistics: GraphPad Prism software (9.1.2, San Diego, USA) was used for all statistical analysis. Statistics: GraphPad Prismsuggested: NoneGraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-